Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2005
01/06/2005CA2529371A1 Cytotoxic depsipeptides
01/06/2005CA2527689A1 Recombinant anti-cd30 antibodies and uses thereof
01/05/2005EP1493817A1 Resistance against plant pests
01/05/2005EP1493815A1 Novel fusion protein recovery and purification methods
01/05/2005EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity
01/05/2005EP1492879A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
01/05/2005EP1492878A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
01/05/2005EP1492874A1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides
01/05/2005EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
01/05/2005EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin
01/05/2005EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
01/05/2005EP1492559A2 Truncated 24 kda basic fibroblast growth factor
01/05/2005EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population
01/05/2005EP1492554A2 Spherical protein particles and methods of making and using them
01/05/2005EP1448760A4 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
01/05/2005EP1301202A4 Genetically-engineered mhc molecules
01/05/2005EP0837930B1 A TRP-226 MUTANT HUMAN GLANDULAR KALLIKREIN-1 (hK2)
01/05/2005EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
01/05/2005EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
01/05/2005EP0699078B1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
01/05/2005DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs
01/05/2005DE10326189A1 Bakterielle Träger für Nukleotidsequenzen kodierend für Wirkstoffe Bacterial support for nucleotide sequences coding for agents
01/05/2005CN1561395A Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
01/05/2005CN1561394A Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
01/05/2005CN1561343A Soluble T cell receptor
01/05/2005CN1560270A Process for preparing active peptide using fish skin collagen step directional enzynolysed by composit enzyme
01/05/2005CN1560258A Preparation process of antibacterial peptide
01/05/2005CN1560254A Gene of L-lactate dehydrogenase, recombined carrier containing said gene and host-cell thereof
01/05/2005CN1560253A Preparation of antibiotic hPAB with multicopy tandem peptide
01/05/2005CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
01/05/2005CN1560245A Enzyme detoxicant and preparation process and application thereof
01/05/2005CN1560241A Mutant of recombined glucokinase for anti blood platelet collecting and low immunogencity
01/05/2005CN1560232A Producing basic proteinase by vibrio metschnikovii DL 33-51 strain
01/05/2005CN1560229A Process of preparing D-amino acid oxydase
01/05/2005CN1560226A Production of agar-agar enzyme by Alteromonas sp.nov.SY 37-12 strain
01/05/2005CN1560082A Chimeric antibod of antihumon recombined basicity fibroblast growth factor and construction and using thereof
01/05/2005CN1560081A Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof
01/05/2005CN1560080A Corpuscles of stannius protein, stanniocalcin
01/05/2005CN1183258C Soya protein oilgopeptides production method
01/05/2005CN1183255C Expression system for producing proteins
01/05/2005CN1183248C Cyclic depsipeptide synthases, genes thereof anjd mass production system of cyclic depsipeptide
01/05/2005CN1183246C Extracellent expression of cellulose binding domains (CBD) using bacillus
01/05/2005CN1183160C Human anti-factor IX/IXa antibodies
01/05/2005CN1183159C Osteoclast forming nihibitory factor monoclonal anti-body, its use and kit
01/05/2005CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant
01/04/2005US6838550 Suppressors of death domains
01/04/2005US6838549 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression
01/04/2005US6838437 Inactivation resistant factor VIII
01/04/2005US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase
01/04/2005US6838281 Cells expressing fusion proteins of immunoglobulins
01/04/2005US6838274 Urocortin proteins and uses thereof
01/04/2005US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains
01/04/2005US6838270 Gene encoding protein capable of regenerating luciferin, novel recombinant DNA, and process for producing protein capable of regenerating luciferin
01/04/2005US6838268 Growing Bacillus sp. IICT 001 in growth medium for 3-4 days to obtain broth, extracting broth with organic solvent, removing solvent and purifying beta-keto aliphatic acid ester compound
01/04/2005US6838264 Antigenic peptide for inducing the formation of antibodies
01/04/2005US6838263 Fusion protein for use as diagnostic tool in genetic engineering
01/04/2005US6838262 Isolated DNA molecule encoding rank ligand
01/04/2005US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins
01/04/2005US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
01/04/2005US6838259 Process for producing kiss-1 peptide
01/04/2005US6838254 Preparing catalytic antibodies for use as diagnostic tools in disease detection
01/04/2005US6838250 Performing competitive immunoassay for detecting C-reactive protein; obtain fliud sample, incubate with antibody, detect signal, corelate signal with c-reactive protein in sample
01/04/2005US6838113 Increasing the digestibility of food proteins by thioredoxin reduction
01/04/2005US6838100 Cultured protein hydrolysate
01/04/2005US6838083 Microbiocides; antibiotics
01/04/2005CA2200563C Calcium free subtilisin mutants
01/04/2005CA2144331C Process for the selective increase of production of antibiotic ge 2270 factor a
12/2004
12/30/2004US20040268426 P2Y4 receptor transgenic and knockout non-human mammals
12/30/2004US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms
12/30/2004US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/30/2004US20040267001 Genes encoding baeyer-villiger monooxygenases
12/30/2004US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents
12/30/2004US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide
12/30/2004US20040266009 Morphological mutants of filamentous fungi
12/30/2004US20040265981 A cDna clone; culturing liver cell in coditioning media
12/30/2004US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/30/2004US20040265974 Human chemokine polypeptides
12/30/2004US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same
12/30/2004US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
12/30/2004US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression
12/30/2004US20040265952 protein containing a modified amino acid that carries an azido or alkynyl group for conjugation to a second molecule such as polymer, label or drug that carries an alkynyl or azido group; translation biochemistry in eukaryotic cells; gene expression inhibitors
12/30/2004US20040265951 Biomimetic gelation system for use as surgical sealant and medical adhesive
12/30/2004US20040265949 Method and building blocks for preparing C-terminally labelled peptides
12/30/2004US20040265936 In gram-negative host cells; immunogenic epitopes from herpes virus; cytokines; interleukins; interferons; tumour necrosis factors; solid phase synthesis; homologous recombination
12/30/2004US20040265929 Detecting huntingtin interactin protein (HIP1) antibodies; for diagnosis/treatment of colon/prostate cancer; drug screening; kits
12/30/2004US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells
12/30/2004US20040265911 Peptides for use in culture media
12/30/2004US20040265910 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods
12/30/2004US20040265908 use of purified metal binding protein, metallothionein from a brine shrimp (Artemia), to reduce the concentration of a metal in a substrate; bioremediation; pollution control
12/30/2004US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/30/2004US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening
12/30/2004US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis
12/30/2004US20040265866 Receptor on the surface of activated T-cells: ACT-4
12/30/2004US20040265857 Cloning gene or fragment thereof via hybridization probe; solid phase synthesis; plasmids; for treating mycosis
12/30/2004US20040265818 Histidine phosphatase interacting protein with 180kd
12/30/2004US20040265809 Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications
12/30/2004US20040265807 Enzymes
12/30/2004US20040265801 Immunoassays for anti-HCV antibodies
12/30/2004US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
12/30/2004US20040265330 Novel compounds